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Human immunodeficiency virus type 1 (HIV-1) enters dendritic cells (DCs) through endocytosis and viral receptor-mediated fusion. Although
endocytosis-mediated HIV-1 entry can generate productive infection in certain cell types, including human monocyte-derived macrophages,
productive HIV-1 infection in DCs appears to be dependent on fusion-mediated viral entry. It remains to be defined whether endocytosed HIV-1 in
DCs can initiate productive infection. Using HIV-1 infection and cellular fractionation assays to measure productive viral infection and entry, here we
show that HIV-1 enters monocyte-derived DCs predominately through endocytosis; however, endocytosed HIV-1 cannot initiate productive HIV-1
infection in DCs. In contrast, productive HIV-1 infection in DCs requires fusion-mediated viral entry. Together, these results provide functional
evidence in understanding HIV-1 cis-infection of DCs, suggesting that different pathways of HIV-1 entry into DCs determine the outcome of viral
infection.
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Dendritic cells (DCs) are among the first target cells that
encounter human immunodeficiency virus type 1 (HIV-1) at the
mucosa. DC-mediated HIV-1 transmission to CD4+ T cells
contributes to the initial stages of viral infection (Piguet and
Steinman, 2007; Wu and KewalRamani, 2006). DCs express
relatively small amounts of HIV-1 receptor and coreceptors and
support low levels of viral replication (Dong et al., 2007; Garcia
et al., 2008; Granelli-Piperno et al., 1998; Pion et al., 2007,
2006). HIV-1 infection of DCs can lead to virus production and
long-term viral transmission (Burleigh et al., 2006; Dong et al.,
2007; Ganesh et al., 2004; Granelli-Piperno et al., 1998; Lore
et al., 2005; Nobile et al., 2005; Smed-Sorensen et al., 2005;
Turville et al., 2004), suggesting that HIV-1-infected DCs may
be a viral reservoir in vivo.⁎ Corresponding author. Fax: +1 414 456 6535.
E-mail address: liwu@mcw.edu (L. Wu).
0042-6822/$ - see front matter © 2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2008.01.044To better understand HIV-1 cis-infection of DCs, it is
important to define viral entry pathway that leads to productive
infection in DCs. Our recent study suggests that HIV-1 enters
DCs primarily through endocytosis rather than fusion between
HIV-1 envelope (Env) and viral receptors at the plasma
membrane (Dong et al., 2007). Although endocytosis-mediated
HIV-1 entry can generate productive infection in certain cell
types, including human monocyte-derived macrophages
(Daecke et al., 2005; Fackler and Peterlin, 2000; Maréchal
et al., 2001), productive HIV-1 infection in DCs appears to be
dependent on fusion-mediated viral entry (Burleigh et al., 2006;
Cavrois et al., 2006; Dong et al., 2007; Nobile et al., 2003;
Nobile et al., 2005; Pion et al., 2007). DCs can efficiently
capture and take up HIV-1 through multiple attachment factors
(Gummuluru et al., 2003; Turville et al., 2001, 2002); however,
it is unclear whether endocytosed HIV-1 can initiate productive
infection in DCs.
Immunofluorescence and electron microscopy studies indi-
cated that internalized HIV-1 particles are sorted and concen-
trated into a low-pH, non-lysosomal compartment in DCs
Fig. 1. HIV-1 infection in immature DCs is blocked by AZT. (A) Surface
expression of CD4 and CCR5 on DCs. Monocyte-derived immature DCs were
stained with specific MAbs and analyzed by flow cytometry. DCs were stained
with either a murine IgG isotypic control antibody (filled peaks) or CD4 MAb
(thick line, left panel) or CCR5 MAb (thick line, right panel). (B) DCs were
infected with R5-tropic HIV-1 Env (JRFL)-pseudotyped, single-cycle lucifer-
ase-reporter HIV-1 (MOI, 0.8) in the presence or absence of AZT. DCs were
lysed 3, 5, and 7 dpi to determine viral infection by measuring the luciferase
activity of cell lysates. Mock infection was used for a background control for the
detection. cps, counts per second. (C) DCs were infected with HIV-1NLAD8 in the
presence or absence of AZT. HIV-1 infection was determined at 3, 5 and 7 dpi by
measuring the p24 levels in supernatants. All data show the means±standard
deviations (S.D.) of triplicate samples. Data for one representative experiment
out of three are shown.
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et al., 2002; Trumpfheller et al., 2003; Turville et al., 2004;Wang
et al., 2007b; Wiley and Gummuluru, 2006). The intracellular
vesicle that confines internalized HIV-1 in DCs has been
characterized as a non-conventional endocytic compartment
enriched in tetraspanins (Garcia, et al., 2008, 2005) or a
multivesicular endosomal body-like compartment (Wiley and
Gummuluru, 2006). Rapid HIV-1 degradation in DCs (Moris
et al., 2004; Nobile et al., 2005; Turville et al., 2004; Wang et al.,
2007b) suggests that the majority of HIV-1 trapped in the
intracellular compartments could be eventually degraded. How-
ever, it remains to be confirmed whether endocytosed HIV-1 in
DCs represents a dead end for viral infection.
Previous studies using a cellular fractionation assay indicated
that the level of HIV-1 Gag p24 in the cytosolic fraction is
correlated with productive viral infection in HIV-1 permissive
cell lines and monocyte-derived macrophages (Maréchal et al.,
1998, 2001). Therefore, the detection of cytosolic p24 shortly
after exposure to HIV-1 is used as an index for productive viral
infection (Maréchal et al., 1998, 2001), which appears to be a
useful assay to study the correlation between the HIV-1 entry
pathway and productive infection.
In this study, by using HIV-1 infection and cellular frac-
tionation assays to measure productive viral infection and entry,
we demonstrate that HIV-1 enters monocyte-derived DCs
predominately through endocytosis; however, endocytosed
HIV-1 cannot initiate productive HIV-1 infection in DCs. In
contrast, productive HIV-1 infection in DCs requires the fusion-
mediated viral entry. These results provide functional evidence
in understanding HIV-1 cis-infection of DCs, suggesting that
different pathways of HIV-1 entry into DCs determine the
outcome of viral infection.
Results
HIV-1 infection in DCs is blocked by a reverse transcriptase
inhibitor
To confirm productive HIV-1 infection in DCs, a reverse
transcriptase inhibitor, 3′-azido-3′-dideoxythymidine (AZT),
was used to block HIV-1 infection in DCs. R5-tropic HIV-1 was
used in this study given that the infection of X4-tropic HIV-1 in
DCs is significantly lower than that of R5-tropic HIV-1 (Ganesh
et al., 2004; Granelli-Piperno et al., 1998; Nobile et al., 2005;
Pion et al., 2007; Wang et al., 2007a). To examine the
expression of the HIV-1 receptor CD4 and coreceptor CCR5,
immature monocyte-derived DCs were stained with the specific
monoclonal antibodies (MAbs) and analyzed by flow cytome-
try. Modest CD4 (86% positive populations) and low levels of
CCR5 (12% positive populations) were detected on DC
surfaces (Fig. 1A). DCs were infected with single-cycle,
luciferase-reporter HIV-1 pseudotyped with R5-tropic Env of
HIV-1JRFL (HIV-JRFL) (Wang et al., 2007a). The HIV-1
proviral genome has env deleted and nef inactivated with a
luciferase-reporter insertion, but contains all other viral genes
(Yamashita and Emerman, 2004). Viral infection was deter-
mined 3, 5 and 7 day post-infection (dpi) by measuring theluciferase activity of DC lysates. HIV-JRFL infection in DCs
was abolished in the presence of AZT (Fig. 1B). Similarly, AZT
inhibited the viral replication of R5-tropic replication-compe-
tent HIV-1NLAD8 in DCs as viral replication was measured by
supernatant p24 of infected DCs (Fig. 1C). No significant
cytotoxicity of AZT was observed at the tested concentration.
These data confirm that the measurement of the luciferase
activity in cell lysates and p24 levels in the supernatants of the
infected DCs represents de novo viral protein synthesis resulting
from the infections.
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in DCs and CD4+ T cells
To compare the relative efficiency of viral infection between
different HIV-1 psuedotypes, single-cycle, luciferase HIV-1
pseudotyped with vesicular stomatitis virus G protein (HIV-
VSV-G) and HIV-JRFL were used to infect DCs and CD4+ Hut/
CCR5 T cells. Hut/CCR5 cells express high levels of the HIV-1
receptor CD4 and coreceptors CCR5 (Wang et al., 2007a). HIV-
VSV-G enters cells through an endocytic pathway and mediates
viral fusion in a low-pH endosome after endocytosis (Aiken,
1997). HIV-1 particles devoid of Env (HIVΔEnv) were used as
a negative control in the infection assay.
When the same p24 amounts of HIV-1 were used in the
infection assay, HIV-VSV-G infection of DCs was 7-fold more
efficient relative to HIV-JRFL infection at 4 dpi, while HIV-
JRFL infection of DCs was only 5% higher when comparedFig. 2. Comparison of HIV-1 infection in DCs and CD4+ T cells with different HIV-1
HIV-VSV-G; the same amount of HIVΔEnv was used as a negative control. DCs were
cultured 4 dpi before measuring the luciferase activity of cell lysates.Mock infectionw
show the means±S.D. of triplicate samples. (B) Direct infection of DCs or Hut/CCR5
flow cytometry for GFP expression 4 dpi. Percentages of GFP-positive cells are showith the negative control HIVΔEnv (Fig. 2A). In contrast, HIV-
VSV-G infection of Hut/CCR5 cells was 51-fold more efficient
relative to HIV-JRFL infection, whereas HIV-JRFL infection of
Hut/CCR5 cells was 10-fold higher relative to the negative
control HIVΔEnv (Fig. 2A). Moreover, HIV-JRFL and HIV-
VSV-G infection of Hut/CCR5 cells was 8-fold and 56-fold
higher than that of DCs, respectively (Fig. 2A).
To confirm the results of HIV-1 infection using luciferase-
reporter HIV-1 pseudotypes, single-cell-based HIV-1 infection
was performed using a green fluorescent protein-expressing
HIV-1 vector (HIV-GFP). The HIV-1-derived vector was
generated from a pNL4-3-based HIV-1 provirus that has
deletions in the env, vif, vpr, vpu, and nef genes; the GFP
gene was inserted in place of the nef open reading frame
(Unutmaz et al., 1999). DCs and Hut/CCR5 cells were
separately infected with HIV-GFP pseudotyped with the Env
of HIV-1JRFL (HIV-GFP/JRFL) or VSV-G (HIV-GFP/VSVG).pseudotypes. (A) Direct infection of DCs or Hut/CCR5 cells with HIV-JRFL and
pulsed with different HIV-1 pseudotypes separately for 2 h at 37 °C, washed and
as used for a background control for the detection. cps, counts per second. All data
cells with HIV-GFP/JRFL or HIV-GFP/VSV-G. Infected cells were analyzed by
wn in the plots. Data for one representative experiment out of three are shown.
Fig. 3. Productive HIV-1 infection in DCs requires fusion-mediated viral entry.
(A) Blockade of fusion-mediated HIV-1 entry into DCs diminishes viral
replication. DCs were infected with HIV-1NLAD8 for 2 h at 37 °C in the presence
or absence of T-20. Supernatants of infected DCs were measured for p24 levels
at 3, 5 and 7 dpi. (B) T-20 does not impair HIV-1NLAD8 endocytosis into DCs.
DC-associated p24 was measured after incubation with HIV-1NLAD8 for 2 h at
37 °C in the presence or absence of T-20. HIV-1-pulsed DCs were extensively
washed, trypsinized and lysed for p24 detection. (C) Endocytosed HIV-1 in DCs
does not generate significant amounts of late reverse transcription (RT) products.
DCs were infected with HIV-1NLAD8, washed, trypsinized, and cultured for 12 h
before the cells were lysed for real-time PCR detection (40 ng of cellular DNA
per sample was used). T-20 was present during the viral incubation and the 12-h
culture. All data show the means±S.D. of triplicate samples. Data for one
representative experiment out of four are shown.
Fig. 4. HIV-1 infection of DCs is pH-independent. HIV-JRFL and HIV-VSV-G
infection of (A) DCs and (B) CD4+ Hut/CCR5 T cell line. DCs or Hut/CCR5
cells were incubated with NH4Cl at 37 °C for 30 min and then pulsed separately
with HIV-VSV-G and HIV-JRFL (MOI, 0.5) at 37 °C for 2 h in the presence of
NH4Cl. NH4Cl was washed away after the 2.5-h incubation with DCs. HIV-1
infection was detected 3 dpi by measuring the luciferase activity of cell lysates
and relative infection is shown. Values for medium controls were set at 100%.
Data for one representative experiment out of three are shown.
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cytometry at 4 dpi. Infection of DCs and Hut/CCR5 cells with
HIV-GFP/VSV-G was approximately 4-fold higher than that
with HIV-GFP/JRFL (Fig. 2B). Infection of Hut/CCR5 cells
with HIV-GFP/JRFL or HIV-GFP/VSV-G was also 4-fold
higher than that of DCs (Fig. 2B). The results of HIV-GFP
vector infection in DCs are in accordance with those of
luciferase-reporter HIV-1, and those in a previous study using
the same HIV-GFP vector (Pion et al., 2006).Productive HIV-1 infection in DCs requires fusion-mediated
viral entry
To investigate whether productive HIV-1 infection in DCs
requires fusion-mediated viral entry, DCs were infected with
HIV-1NLAD8 in the presence of HIV-1 fusion inhibitor T-20, a
small synthetic peptide inhibiting fusion-mediated HIV-1 entry
(Wild et al., 1993). The T-20 treatment efficiently blocked HIV-
1NLAD8 infection in DCs to background levels (Fig. 3A),
suggesting that fusion-mediated viral entry is required for
productive HIV-1 replication in DCs. No significant cytotoxi-
city of T-20 was observed at the tested concentration.
To examine whether T-20 blocked HIV-1 entry into DCs,
DCs were pulsed with HIV-1NLAD8 in the presence or absence of
T-20, and trypsinized after extensive washes to strip cell-surface
bound HIV-1. The p24 levels in the lysates of DCs were then
quantified. Blockade of viral fusion with T-20 did not result in a
reduction of total viral entry into DCs (Fig. 3B). Furthermore, to
determine whether endocytosed HIV-1NLAD8 in DCs can
complete the reverse transcription process, DCs were pulsed
with HIV-1NLAD8 and cultured for 12 h before detection of late
reverse transcription products by real-time PCR. In the presence
of T-20, HIV-1 late reverse transcription products were
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DNA, the detection limit was 10 copies) (Fig. 3C), indicating
that fusion-mediated viral entry is necessary for productive
synthesis of viral DNA. These results are in agreement with
those in a previous report (Nobile et al., 2005). Together, these
results suggest that HIV-1 enters DCs primarily through
endocytosis; however, fusion-mediated viral entry is required
for productive infection. These results also suggest that
endocytosis-mediated HIV-1 entry into DCs cannot lead to
productive viral infection.
HIV-1 infection of DCs is pH-independent
To blockHIV-VSV-G infection, DCswere infected with HIV-
VSV-G in the presence of the weak base ammonium chloride
(NH4Cl), which blocks acidification of endosomal compart-
ments. NH4Cl was washed away after the 2.5 h incubation with
DCs; no significant cytotoxic effects on DCswere observed after
3 days in culture, as we recently reported (Wang et al., 2007b).
Compared with the medium control, the NH4Cl treatment
significantly decreased HIV-VSV-G infection in DCs by 82%
(Fig. 4A, Pb0.01, Wilcoxon's paired t test). In contrast, HIV-Fig. 5. Analysis of HIV-1 entry into DCs by cellular fractionation. (A) Cellular frac
JRFL, and HIV-VSV at 37 °C for 2 h. After extensive washes, DCs were treated w
permeabilized, and fractionated. Intracellular p24 levels were measured in the cytos
shown inside the bars. The average results of four independent experiments using DC
vesicular fractionations of HIV-infected DCs. HIV-pulsed DCs were fractionated as d
for Cu/Zn-SOD (cytosol marker) and LAMP-1 (vesicle marker). Data for one represe
vesicular fractionations of DCs treated with fusion inhibitors. DCs were pretreated s
presence of the appropriate inhibitors. DCs were then washed and fractionated, and the
cytosolic and vesicular p24 are shown inside the bars. Data for one representative eJRFL infection in DCswas increased by 1.7-fold with the NH4Cl
treatment (Fig. 4A). Similar results were obtained using Hut/
CCR5 T cells in the infection (Fig. 4B). These data confirm that
HIV-VSV-G infection of DCs is low pH-dependent, while R5-
tropic HIV-JRFL infection of DCs is pH-independent.
Analysis of HIV-1 entry into DCs by cellular fractionation
To better understand HIV-1 entry into DCs, HIV-pulsed DCs
were analyzed by cellular fractionation as previously described
(Maréchal et al., 2001). DCs were separately exposed to the
same p24 amounts of HIV-JRFL and HIV-VSV-G. HIVΔEnv
was used as a background control to assess non-specific viral
uptake. After extensive washes, DCs were treated with pronase
to remove viral particles adsorbed on the cell surfaces, and then
the plasma membranes of DCs were permeabilized with
digitonin, a mild nonionic detergent. DCs were then fractionated
by centrifugation, and intracellular p24 levels in the cytosolic
and vesicular fractions were quantified.
The average results of four independent experiments of the
cellular fractionation indicate that the total intracellular p24 in
HIV-VSV-G-exposed DCs was 2.4-fold (Pb0.05) and 1.4-foldtionation of HIV-pulsed DCs. DCs were separately exposed to HIVΔEnv, HIV-
ith pronase to remove HIV-1 bound on cell surface. DCs were then washed,
olic and vesicular fractions. The percentages of cytosolic and vesicular p24 are
s from different donors are shown. (B) Western blot analysis of the cytosolic and
escribed above in (A) and analyzed by Western blotting with antibodies specific
ntative experiment out of three are shown. (C) Relative p24 of the cytosolic and
eparately with NHCl4 and T-20, pulsed with different HIV-1 pseudotypes in the
p24 levels were measured as described above in (A). The relative percentages of
xperiment out of three are shown.
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respectively (Fig. 5A). These data indicate that DCs take up
HIV-VSV-G more efficiently than HIVΔEnv and HIV-JRFL.
The total p24 of HIV-JRFL-exposed DCs was 1.8-fold higher
than that of HIVΔEnv-exposed DCs. Interestingly, 70% of the
total p24 was detected in the cytosolic fraction of HIV-VSV-G-
exposed DCs, which is significantly higher (Pb0.001, Dun-
nett's multiple comparison test) than 52% and 55% of p24
cytosolic fractions in HIVΔEnv- and HIV-JRFL-exposed DCs,
respectively (Fig. 5A). These results suggest that HIV-VSV-G
has a more productive entry than HIV-JRFL due to efficient
viral fusion within endosomal compartments.
Notably, the cytosolic p24 fraction detected in HIV-JRFL-
exposed DCs was only 3% higher than that in HIVΔEnv-
exposed DCs (Fig. 5A), indicating that HIV-JRFL enters DCs
mainly through endocytosis despite appropriate interactions
between viral receptors and Env. The cytosolic p24 fraction in
HIV-JRFL-exposed DCs appears to correlate well with the HIV-
1 infection results, in which HIV-JRFL infection of DCs was
only 5% higher than that of control HIVΔEnv (Fig. 2A).
Together, these data suggest that the cytosolic p24 fraction can
be used as an indicator for productive infection. These results
also imply that, unlike HIV-VSV-G, endocytosed HIV-JRFL in
DCs likely failed to escape from intracellular compartments and
to initiate productive infection.
To verify the specificity of the fractionation assay, the cellular
fractions were analyzed in parallel by Western blotting with the
antibodies specific for the markers of cytosolic and vesicular
fractions. Copper/zinc superoxide dismutase (Cu/Zn-SOD) was
used as a specific marker for the cytosolic fractions (Crapo et al.,
1992), while lysosomal-associated membrane protein 1 (LAMP-
1) was used as a maker for the vesicular fractions (Chen et al.,
1988;Maréchal et al., 1998). As expected, Cu/Zn-SODwas only
detected in the cytosolic fractions, but not in the vesicular
fractions, whereas LAMP-1 was highly enriched in the vesicular
fractions (Fig. 5B). The trace amounts of LAMP-1 observed in
the cytosolic fractions (Fig. 5B) might result from minimal
contamination. Thus, these Western blotting results validate the
cellular specificity of the fractionation assay.
To investigate whether the presence of fusion inhibitors can
alter the cytosolic p24 fractions of HIV-1 pseudotyped with
different envelope proteins, T-20 and NH4Cl were separately
used to inhibit the fusion of HIV-JRFL and HIV-VSV-G to DCs
in the fractionation assays. DCs were pretreated separately with
NHCl4 and T-20, pulsed with different HIV-1 pseudotypes in the
presence of the appropriate inhibitors. DCs were then fractio-
nated, and the p24 levels in the cytosolic and vesicular fractions
were measured. For HIV-JRFL-infected DCs, the T-20 treatment
reduced the cytosolic p24 fraction from 46% to 33% (relatively,
28% reduction), whereas the NH4Cl treatment did not affect the
p24 fractions (Fig. 5C, central panel). For HIV-VSV-G-infected
DCs, the NH4Cl treatment efficiently reduced the cytosolic p24
fraction from 65% to 27% (relatively, 58% reduction) and
reversed the relative p24 in the vesicle and cytosol fractions
compared with the medium control, while the T-20 treatment did
not strongly alter the cytosolic p24 fraction (Fig. 5C, right
panel). For the HIVΔEnv controls, the NH4Cl and T-20treatments slightly decreased the cytosolic p24 fractions by
9% and 7%, respectively, which were likely due to experimental
variations (Fig. 5C, left panel). Together, these results suggest
that specific fusion inhibitors can alter the cytosolic p24
fractions in DCs infected by different HIV-1 pseudotypes.
Discussion
DCs can efficiently take up HIV-1 and release infectious
viruses to cocultured CD4+ T cells through viral trafficking
(Dong et al., 2007; Ganesh et al., 2004; Garcia et al., 2005;
Gummuluru et al., 2003; Kwon et al., 2002; McDonald et al.,
2003; Turville et al., 2004; Wang et al., 2007b; Wiley and
Gummuluru, 2006). In addition to DC-mediated HIV-1 trans-
infection, HIV-1-infected DCs can act as infectious viral
reservoirs and mediate long-term viral dissemination (Piguet
and Steinman, 2007; Wu and KewalRamani, 2006). Defining
HIV-1 entry pathways that lead to productive viral infection in
DCs can enhance our understanding of HIV-DC interactions. In
this study, using viral infection and cellular fractionation assays,
we characterized HIV-1 entry and infection of DCs with
replication-competent and single-cycle HIV-1. Our results
suggest that HIV-1 enters monocyte-derived DCs predominately
through endocytosis; however, endocytosis-mediated HIV-1
entry into DCs is not able to generate productive viral infection.
In contrast, productive HIV-1 infection in DCs depends on the
fusion-mediated viral entry pathway (depicted as a proposed
model in Fig. 6).
Low levels of CD4 and CCR5 expression in DCs (Fig. 1A)
could contribute to inefficient fusion between JRFL-pseudo-
typed HIV-1 and DCs at the plasma membrane, resulting in less
productive viral infection in DCs (Fig. 2). Postentry restriction
of HIV-1 infection in DCs also plays a role in a less productive
viral infection (Peng et al., 2007; Pion et al., 2006). Our results
of DC infection with VSV-G-pseudotyped HIV-1 vectors also
suggest potential postentry restriction of HIV-1 infection in
DCs. For instance, HIV-VSV-G infection of DCs was only 7-
fold more efficient compared with HIV-JRFL infection
(Fig. 2A). In contrast, the relative infectivity of the same
stock of HIV-VSV-G (2193 infectious units/ng p24) was 26-
fold higher than that of HIV-JRFL (85 infectious units/ng p24)
in a flow cytometry-based titration assay. The viral titration was
performed using GHOST/R5 cells, which are human osteosar-
coma cells expressing high levels of CD4 and CCR5. These
cells contain a GFP gene under the control of the HIV-2 LTR
promoter, which is expressed during HIV-1 infection via Tat
transactivation, acting as a sensitive indicator of HIV-1 infection
(Cecilia et al., 1998).
Although T-20 efficiently blocked HIV-1 infection in DCs
(Fig. 3A), HIV-1 endocytosis in DCs could not be impaired by
T-20 (Fig. 3B). A previous study reported that T-20 efficiently
inhibits HIV-1 cis- and trans-infection of monocyte-derived
DCs (Ketas et al., 2003). However, T-20 was present in the DC-
T-cell cocultures in that study, which could block HIV-1 in-
fection in cocultured T cells rather than the viral transmis-
sion process. HIV-1 endocytosed in DCs can be rapidly and
efficiently transmitted to cocultured CD4+ T cells (Dong et al.,
Fig. 6. A proposed model for HIV-1 entry and productive infection in DCs. HIV-1 enters DCs through the endocytosis and plasma membrane fusion pathways. The
endocytic pathway appears to be the predominate route of HIV-1 entry into DCs; however, only fusion-mediated HIV-1 entry can lead to productive HIV-1 infection. In
the cellular fractionation assay, the vesicular p24 fraction represents the HIV-1 confined in the endocytic compartments; whereas the cytosolic p24 fraction represents
the HIV-1 entered through the fusion pathway. Endocytosed HIV-1 could be eventually degraded. However, it is currently uncertain whether a small proportion of
internalized authentic HIV-1 in DCs can escape the vesicular compartment via potential intravesicular fusion.
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2004; Wang et al., 2007a). The inefficient block of HIV-1
uptake in DCs with T-20 implies that endocytosed HIV-1 in
DCs may recycle to the cell surface and mediate trans-infection
at the infectious/virological synapse (Arrighi et al., 2004; Gar-
cia et al., 2008, 2005; McDonald et al., 2003; Turville et al.,
2004).
The block of HIV-1 infection in DCs by T-20 indicated the
requirement for Env-mediated viral fusion; however, this result
could not address the question where the fusion occurs. T-20
presented during the HIV-1 incubation with DCs could be
internalized together with HIV-1 into the endocytic compart-
ment of DCs. Although the acidic environment of the vesicular
compartment might inactivate T-20, it is possible that T-20
could block HIV-1 fusion within the low-pH vesicles. However,
it is currently uncertain whether a small proportion of
internalized authentic HIV-1 in DCs can escape the vesicular
compartment via intracellular fusion (Fig. 6), which is the
fusion mechanism of VSV-G-pseudotyped HIV-1 (Aiken,
1997). In rare cases, intravesicular fusion between HIV-1 and
the vesicular membrane was observed in monocyte-derived
macrophages by electron microscopy (Maréchal et al., 2001),
suggesting that a small part of intravesicular HIV-1 may escape
the endocytic pathway and enter the cytoplasm. However, we
were not able to observe such intravesicular viral fusion in ourelectron microscopy studies of HIV-1 interactions with DCs
[(Wang et al., 2007b) and Wang and Wu, unpublished results].
A virion-based HIV-1 fusion assay has been used to measure
the fusion of HIV-1 virions to DCs (Cavrois et al., 2006; Pion
et al., 2007). Low levels of viral fusion (2–6%ofDC populations)
were detected by flow cytometry with the fusion assay using a
high viral input (300 to 500 ng of p24 per 2×105 DCs) (Cavrois
et al., 2006), suggesting inefficient HIV-1 fusion to DCs. The
assay is based on the delivery of beta-lactamase (BlaM)-Vpr-
incorporated HIV-1 into the cytoplasm of target cells upon virion
fusion (Cavrois et al., 2002). BlaM can cleave a fluorescent
substrate CCF2 dye loaded in the target cells and change its
fluorescence emission, thereby allowing viral fusion to be de-
tected. Although the virion-based fusion assay detects entry of
HIV-1 by fusion, but not by endocytosis, given that intravesicular
fusion of HIV-1 unlikely occurs efficiently (Cavrois et al., 2002),
this assay might not be able to distinguish HIV-1 plasma mem-
brane fusion from potential intravesicular fusion.
Inhibition of endosome acidification can increase HIV-1
infection by decreasing viral degradation (Fredericksen et al.,
2002) and enhancing viral fusion (Schaeffer et al., 2004). In our
experiments, the NH4Cl treatment of DCs and CD4
+ T cells
slightly increased HIV-JRFL infection (less than 2-fold), but
blocked HIV-VSV-G infection (Fig. 4). These observations are
consistent with previous results obtained from various cell types
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Fredericksen et al., 2002; Nobile et al., 2005; Schaeffer et al.,
2004).
In a previous study using the cellular fractionation assays,
after exposure of HIVΔEnv to macrophages, the detection of
27% of total p24 in the cytosolic fraction of macrophages likely
represents background contamination (Maréchal et al., 2001). In
contrast, an average of 52% (ranged from 27% to 71% in four
independent experiments) of total p24 was detected in the
cytosol fraction of HIVΔEnv-exposed DCs (Fig. 5A), which
might be due to the incomplete removal of viral particles bound
on DC surfaces. It is also possible that during the permeabiliza-
tion of the plasma membrane with digitonin, DC surface bound
viral particles were released into the cytosolic fraction, resulting
in an increased p24 background in the cytosolic fraction. Our
recent study indicates that a portion of DC-associated HIV-1 is
protected from pronase treatment, and is able to mediate trans-
infection of cocultured CD4+ T cells (Wang et al., 2007b).
Based on our titration of the pronase concentration used for DCs
(Wang et al., 2007b), to ensure the integrity of DC plasma
membranes before the permeabilization, the pronase concentra-
tion used in our study was 4-fold lower than that used in
macrophage fractionations (Maréchal et al., 2001). Our Western
blot analysis confirmed the specificity of the subcellular
fractions, indicating no strong cross contamination between
the vesicular and the cytosolic fractions (Fig. 5B). The Western
blot analysis has not been shown in the previous studies using
the cellular fractionation assay (Maréchal et al., 1998, 2001).
Notably, the total p24 of HIV-JRFL-exposed DCs was about
2-fold higher than that of HIVΔEnv-exposed DCs, which might
result from multiple receptor-mediated binding and internaliza-
tion of HIV-JRFL, in addition to non-specific endocytosis-
mediated viral uptake. HIV-1 Env interactions with CD4, the C-
type lectin DC-SIGN, and other attachment factors on DCs can
facilitate viral binding and endocytosis (Gummuluru et al.,
2003; Turville et al., 2001, 2002; Wang et al., 2007a,b).
Interestingly, the treatment with specific fusion inhibitors in
HIV-1-infected DCs had altered cytosolic p24 distributions. The
T-20 and NH4Cl treatment of DCs efficiently reduced the
cytosolic p24 fraction in HIV-JRFL-infected DCs and HIV-
VSV-G-infected DCs, respectively. These results further
validate that the cytosolic p24 fraction could be used as an
indirect indicator to reflect productive HIV-1 infection in DCs.
The majority of endocytosed HIV-1 in intracellular compart-
ments in DCs will eventually be degraded. Indeed, rapid
intracellular HIV-1 degradation has been reported in DCs (Moris
et al., 2004; Nobile et al., 2005; Turville et al., 2004; Wang et al.,
2007b). A recent study suggests that Langerin-mediated HIV-1
internalization results in viral degradation, thereby inhibiting
HIV-1 replication in Langerhans cells (de Witte et al., 2007).
HIV-1 enters intraepithelial vaginal Langerhans cells primarily
by multiple receptor-mediated endocytosis, and virions re-
mained intact within the cytoplasm for several days without
productive replication (Hladik et al., 2007). However, when
HIV-1-bearing DCs encounter CD4+ T cells prior to viral
degradation, efficient HIV-1 trans-infection of CD4+ T cell can
occur in vitro (Dong et al., 2007; Hladik et al., 2007; McDonaldet al., 2003; Izquierdo-Useros et al., 2007; Turville et al., 2004),
suggesting that DCs may act as a potential viral reservoir to
disseminate HIV-1 infection in vivo.
Materials and methods
Cell culture
Immature DCs were generated from purified CD14+ mono-
cytes treated with 50 ng/ml of granulocyte-macrophage colony-
stimulating factor and interleukin 4 for 5 days as described
previously (Dong et al., 2007). Immature DCs were more than
98.5% pure by DC-SIGN, HLA-DR, CD11b, and CD11c
staining, but negative for CD3 and CD14 (Wang et al., 2007b).
The human embryonic kidney cell line HEK293T, CD4 T-cell
line Hut/CCR5, and HIV-1 indicator cell line GHOST/R5 have
been described (Wang et al., 2007a).
Flow cytometry
DCs were stained with specific MAbs or isotype-matched
immunoglobulin G (IgG) controls as previously described
(Wang et al., 2007a). Phycoerythrin-conjugated mouse anti-
human CD4 (clone S3.5) and goat anti-mouse IgG were
purchased from Caltag Laboratories. Purified mouse anti-human
CCR5 (clone 45531) was purchased from R&D Systems. Stained
cells were analyzed using a FACSCalibur flow cytometer and
CellQuest program (Becton Dickinson) or FlowJo software (Tree
Star).
HIV-1 stocks
Single-cycle, luciferase-reporter HIV-1 stocks were gener-
ated by cotransfections of HEK293T cells with pLai3ΔenvLuc2
(Yamashita and Emerman, 2004), an env-deleted and nef-
inactivated HIV-1 proviral construct (a kind gift from Michael
Emerman, Fred Hutchinson Cancer Research Center, Seattle,
WA) and expression plasmids for VSV-G or R5 HIV-1 envelope
JRFL as previously described (Dong et al., 2007; Wang et al.,
2007a). HIV-GFP pseudotyped viral stocks were generated by
cotransfections of HEK293T cells with pHIV-eGFP (a kind gift
from Vineet KewalRamani, National Cancer Institute-Freder-
ick, MD) and pJRFL or pVSV-G as previously described
(Unutmaz et al., 1999). The infectivities of the virus stocks were
evaluated by limiting dilution on GHOST/R5 cells (Wu et al.,
2002).
Replication-competent HIV-1NLAD8 was generated by trans-
fections of HEK293T cells with the proviral construct pNLAD8
(Freed et al., 1995) (a kind gift from Eric Freed, National
Cancer Institute-Frederick, MD). To minimize the contamina-
tion of HIV-1NLAD8 stocks with plasmid DNA, Hut/CCR5 cells
were infected with HEK293T-derived HIV-1NLAD8, and super-
natants were harvested 5 dpi as previously described (Dong
et al., 2007). Gag p24 concentrations of HIV-1NLAD8 stocks
were measured using an enzyme-linked immunosorbent assay
(ELISA, anti-p24-coated plates were purchased from the AIDS
Vaccine Program, SAIC, Frederick, MD).
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To measure HIV-1 entry, DCs were pulsed with HIV-1NLAD8
for 2 h at 37 °C, cells were trypsinized after extensive washes,
and then lysed with 200 μl of 1% Triton X-100 buffer for Gag
p24 quantification by ELISA as previously described (Wang
et al., 2007a). HIV-1 direct infection assays using luciferase-
reporter HIV-1 were performed as previously described (Dong
et al., 2007). Cell lysates were analyzed for luciferase activity
with a commercially available kit (Promega). For infection of
HIV-1NLAD8, DCs (2×10
5) were pulsed with HIV-1NLAD8
(20 ng p24) at 37 °C for 2 h. When indicated, DCs were
pretreated with 1 μM of HIV-1 fusion inhibitor T-20 (the NIH
AIDS Reagents Program) at 37 °C for 30 min, and T-20 was
maintained at the same concentration during the viral incubation
(Dong et al., 2007). For infection using HIV-GFP pseudotypes,
DCs (2×105) or Hut/CCR5 cells (1×105) were infected with
either HIV-GFP/JRFL or HIV-GFP/VSV-G (multiplicity of
infection [MOI], 0.5∼1). Infected cells were fixed and analyzed
for GFP expression by flow cytometry as previously described
(Unutmaz et al., 1999). A total of 1×104 cells was analyzed for
each sample.
Real-time PCR quantification of HIV-1 DNA in infected DCs
DCs (2×105) were infected with HIV-1NLAD8 (20 ng p24)
that have been pretreated with 60 U/ml of DNase I (Fermenta) at
37 °C for 1 h as previously described (Dong et al., 2007). Total
cellular DNA was extracted 12 h post-infection from the
infected DCs with a Blood DNA kit (Qiagen). Cellular DNA
was quantified and normalized with real-time PCR quantifica-
tion of glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
as described (Dong et al., 2007). Primers, probes, and real-time
PCR conditions for the detection of HIV-1 late reverse
transcription products were previously described (Dong et al.,
2007).
Analysis of HIV-1 entry into DCs by cellular fractionation
DCs were separately exposed to HIVΔEnv, HIV-JRFL and
HIV-VSV (225 ng of p24 per 1×106 DCs) for 2 h at 37 °C.
After extensive washes, DCs were treated with 0.25 mg/ml of
pronase E (Sigma-Aldrich) to remove HIV-1 bound on cell
surface. DCs were then washed, permeabilized with digitonin
(Sigma-Aldrich), and fractionated by centrifugation as pre-
viously described (Maréchal et al., 2001). Intracellular p24
levels in the cytosolic and vesicular fractions were measured by
ELISA as previously described (Wang et al., 2007a). For T-20
and NH4Cl inhibitor treatments, DCs were preincubated with
1 μMof T-20 or 10 mM of NH4Cl at 37 °C for 30 min before the
HIV-1 incubation. Inhibitor concentrations were maintained at
the same concentration during the virus incubation.
Western blotting
DC lysates were quantified and normalized by bicinchoninic
acid protein assay (Pierce) according to the product instruction.Samples were separated on a 13% sodium dodecyl sulfate-
polyacrylamide gel, and transferred to Immobilon-P membranes
(Millipore) for Western blotting. The membrane was probed
sequentially with anti-Cu/Zn-SOD (1:1000; Calbiochem) and
anti-LAMP-1 (1:2000; clone H4A3, BD Pharmingen) as the
primary antibodies. Horseradish peroxidase (HRP)-conjugated
anti-sheep IgG (1:5000, Jackson ImmunoResearch Labora-
tories) or anti-mouse IgG (1:5000; Promega) was used as
secondary antibodies. Restore Western Blot Stripping buffer
(Pierce) was used to strip antibodies from probed membranes.
SuperSignal West Pico chemiluminescence reagents (Pierce)
were used to detect HRP-conjugated secondary antibody.
Statistical analyses
Statistical analyses were performed with theWilcoxon paired
t test or Dunnett's multiple comparison test with Prism software.
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